Ruey-min Lee

2 Patents

• US123502752025

  Compositions and Methods for Immune-mediated Cancer Therapy

  TECLISON, Inc.

  0 cites
• US117608072023

  Gpc3-targeting Drug Which Is Administered to Patient Responsive to Gpc3-targeting Drug Therapy

  F. Hoffmann-la Roche AG

  0 cites